François Girodon

Leukemic blasts in transformed JAK2-V617F–positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

Alexandre Theocharides, Marjorie Boissinot, François Girodon et al. · Blood · 2007 · 320 citations

Medicine, Hematology, Molecular Genetics +14

Impact of Trace Elements and Vitamin Supplementation on Immunity and Infections in Institutionalized Elderly Patients

François Girodon · Archives of Internal Medicine · 1999 · 291 citations

Life Sciences, Geriatric Medicine, Nutritional Sciences +16

A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

Francesco Passamonti, Jürgen Thiele, François Girodon et al. · Blood · 2012 · 266 citations · Full text

Medicine, Hematology, Internal Medicine +17

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

Éric Lippert, Marjorie Boissinot, Róbert Královics et al. · Blood · 2006 · 235 citations · Full text

Medicine, Genetics, Hematology +7

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

Francesco Passamonti, Chiara Elena, Susanne Schnittger et al. · Blood · 2011 · 224 citations

Medicine, Genetics, Molecular Genetics +13